Cells, 2021 · DOI: 10.3390/cells10010073 · Published: January 5, 2021
This study investigates a potential treatment for spinal cord injury (SCI) using biofunctionalized electroconducting microfibers (MFs). These MFs are designed to provide signals that guide regenerating axons across damaged tissue. The researchers used a mouse model of SCI and implanted MFs coated with cell adhesion molecules and growth factors. They then used advanced imaging techniques to observe the responses of axons and immune cells in real-time. The results showed that the MFs were biocompatible, promoted axon growth and alignment, and modulated the immune response in a beneficial way, suggesting they could be a promising strategy for SCI management.
Biofunctionalized microfibers could be developed as a therapeutic approach to promote axon regeneration and improve functional outcomes after spinal cord injury.
The ability of MFs to modulate the immune response suggests potential for promoting tissue repair and reducing inflammation in SCI.
The study highlights the importance of biocompatible and pro-regenerative biomaterials in the design of effective SCI therapies.